Industry Focus

Motley Fool's Michael Douglass and Todd Campbell shed light on how Celgene's deal-making frenzy positions it as a potential MS leader and offer up insight into how to value immuno-oncology stocks.

Direct download: 150715_IF_Healthcare.mp3
Category:Podcast -- posted at: 5:47pm EDT

As Comic-Con wraps up, movie goers are sitting on the edge of their seats waiting for the next flick to thrill them once again.

Direct download: 150714_IF_ConsumerGoods.mp3
Category:Podcast -- posted at: 8:06pm EDT

1